INVITATION: Join Me for a Live Session on Personalised Drug Repurposing in Cancer Care
Amanda, the Metabolic Nutritionist, will co‑host a live conversation with author and metabolic oncology researcher Travis Christofferson on drug repurposing in precision oncology. The event, organized by Astron Health, will explore how approved medications can be matched to cancer patients through molecular profiling. Attendees will learn about the intersection of metabolic and precision oncology and receive practical guidance for navigating repurposed‑drug options. The session is scheduled for April 28 at 1 pm BST (8 am EDT).
Cancer Resistance and Interventions to Mitigate Resistance – Part 1
The post outlines how multi‑agent metabolic regimens—using repurposed drugs and nutraceuticals—initially suppress tumors but often trigger adaptive resistance after about two years. Resistance arises from metabolic plasticity, enrichment of cancer‑stem‑cell‑like subpopulations, and rewiring of stress‑signaling pathways. The author proposes press‑pulse,...
Ivermectin & Fenbendazole - Bridging the Gap - Repurposed Drugs in Naturopathic Oncology
Amanda King ND’s recent post highlights the growing interest in repurposing ivermectin and fenbendazole as adjuncts in naturopathic oncology. She outlines pre‑clinical evidence suggesting anti‑cancer properties for both agents and discusses how they fit into an integrative treatment protocol. The...